Abstract:To evaluate the efficacy of intensity-modulated radiation therapy (IMRT) using reduced clinical target volumes for regional lymph nodes (CTV-N) in the treatment of nasopharyngeal carcinoma (NPC). From January 2006 to December 2010, a total of 1,208 patients with NPC treated with IMRT according to our institutional protocol were collected in the current study. The CTV-N was contoured according to DAHANCA, EORTC, GORTEC, NCIC, and RTOG consensus guidelines but the level I, the retrostyloid space, and the medial retropharyngeal nodes below the cranial edge of the second cervical vertebra (C2) were spared. Patients with locoregionally advanced disease were also prescribed cisplatin-based chemotherapy. With a median follow-up of 57 months (range, 2-102 months), 33 patients had developed regional failure, of which, 22 patients encountered recurrence in the irradiation field and only 11 patients (1%) experienced relapse outside the irradiation field. The 5-year overall survival, distant metastasis-free survival, regional relapse-free survival, and local relapse-free survival were 80.8%, 82.6%, 96.8%, and 93.2% respectively. Multivariate analyses revealed that the N-classification was the only significant prognostic factor for predicting regional relapse-free survival. The IMRT approach using reduced CTV-N sparing the level I, the retrostyloid space, and the medial retropharyngeal nodes below the cranial edge of C2 for NPC is suitable.

Nasopharyngeal Carcinoma Treated with Intensity Modulated Radiation Therapy Using A Reduced Clinical Target Volume for the Neck Nodal Regions